Connecting you to content on EBSCOhost

Works by Schwartz GK

Results: 2

1

Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting: lymphocyte count after 2 doses correlates with survival.

Published in:

2010

By:

Ku GY;
Yuan J;
Page DB;
Schroeder SE;
Panageas KS;
Carvajal RD;
Chapman PB;
Schwartz GK;
Allison JP;
Wolchok JD;
Ku, Geoffrey Y;
Yuan, Jianda;
Page, David B;
Schroeder, Sebastian E A;
Panageas, Katherine S;
Carvajal, Richard D;
Chapman, Paul B;
Schwartz, Gary K;
Allison, James P;
Wolchok, Jedd D

Publication type:

journal article

2

Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancer.

Published in:

2008

By:

Ku GY;
Ilson DH;
Schwartz LH;
Capanu M;
O'Reilly E;
Shah MA;
Kelsen DP;
Schwartz GK;
Ku, Geoffrey Y;
Ilson, David H;
Schwartz, Lawrence H;
Capanu, Marinela;
O'Reilly, Eileen;
Shah, Manish A;
Kelsen, David P;
Schwartz, Gary K

Publication type:

journal article